Cyclooxygenases in pancreatic ductal adenocarcinoma: are they inflammatory catalysts for tumor growth
{{output}}
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers with a relative 5-year survival around 12%. One of the greatest challenges in PDAC is the frequent systemic dissemination at the time of diagnosis and the dense, fibrotic extracellu... ...
